Search

everythinglearnresearchcommunity

for

Search:↓

Deuruxolitinib effectively treats alopecia areata but may cause manageable side effects.

Retinoic acid helps activate hair growth in people with common hair loss by working on a specific cell growth pathway.

Combining baricitinib with low-dose corticosteroids significantly improved severe hair loss in eight patients.

Baricitinib effectively treated alopecia areata in 73% of patients, with minor metabolic changes and significant changes in inflammatory markers.

Intralesional triamcinolone acetonide can regrow hair in alopecia areata but often has temporary effects and side effects.

Ritlecitinib helps hair regrowth and reduces emotional and functional burdens in alopecia areata.

Low-dose oral naltrexone may help reduce inflammation in some scarring alopecia patients.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

Oral JAK inhibitors effectively treat alopecia areata and are generally well-tolerated.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

Combining light therapy, acid, and microneedling improves hair regrowth in stubborn hair loss cases.

Leflunomide may reduce the risk of alopecia areata, while methotrexate, cyclosporine, and rituximab may increase it.

Oral tofacitinib can treat both psoriasis and alopecia universalis by normalizing inflammatory pathways.

Child with rickets improved with a specific vitamin D therapy, but alopecia did not change.

Apremilast improved symptoms in patients with severe skin conditions.

JAK inhibitors show promise for treating alopecia areata but have serious side effects.

Topical PUVA and tacrolimus ointment can effectively and safely treat infant alopecia universalis.

New drugs for alopecia areata show promise but aren't universally effective, and hair loss often returns after stopping treatment.

A woman with rheumatoid arthritis lost all her hair during adalimumab treatment, and stopping the drug didn't help.

JAK inhibitors effectively regrow hair in children with alopecia areata and are safe to use.

Baricitinib helps regrow hair in severe alopecia areata but has side effects like infections and headaches.

JAK inhibitors improve hair growth in alopecia areata, especially in patchy types.

New cytokine-targeted therapies show promise for treating alopecia areata.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Continued baricitinib treatment leads to significant scalp hair regrowth in severe alopecia areata patients.

Deucravacitinib helped a man regrow hair significantly.

Altered retinoid metabolism in cicatricial alopecia suggests a balanced vitamin A diet may prevent the condition.

Baricitinib is generally safe for long-term use in treating severe alopecia areata.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.